Is SRTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SRTS. It does not provide personalized investment advice.

SRTS (Sensus Healthcare, Inc) Stock Analysis - Financials

Sensus Healthcare, Inc (SRTS) is a publicly traded Healthcare sector company. As of July 30, 2026, SRTS trades at $2.90 with a market cap of $46.92M and a P/E ratio of -6.18. SRTS moved +2.46% today. Year to date, SRTS is -29.51%; over the trailing twelve months it is -45.37%. Its 52-week range spans $2.66 to $9.08. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces SRTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SRTS's key financials?

SRTS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SRTS recently traded at $2.90. Market cap is $46.92M. P/E ratio is -6.18. Revenue is $22.53M.

SRTS Key Metrics

Key financial metrics for SRTS
Metric	Value
Price	$2.90
Market Cap	$46.92M
P/E Ratio	-6.18
EPS	$-0.47
Dividend Yield	0.00%
52-Week High	$9.08
52-Week Low	$2.66
Volume	12.40K
Avg Volume	0
Revenue (TTM)	$22.53M
Net Income	$-7.77M
Gross Margin	37.74%

SRTS Analyst Consensus

3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.

Common questions about SRTS

What are SRTS's key financials?: SRTS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SRTS recently traded at $2.90. Market cap is $46.92M. P/E ratio is -6.18. Revenue is $22.53M.
Is SRTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SRTS. It does not provide personalized investment advice.